1
Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin
Condition(s):Safety and TolerabilityLast Updated:February 20, 2017Completed
Finafloxacin as an Intervention: 7 Clinical Trials
Hide Studies Not Open or Pending
2
Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
Condition(s):Urinary Tract InfectionsLast Updated:June 11, 2009Completed
3
Effect of Age and Gender on the PK and Tolerability of Finafloxacin
Condition(s):Pharmacokinetic and Tolerability of FinafloxacinLast Updated:July 22, 2013Completed
4
First Time in Man Study of Finafloxacin Hydrochloride
Condition(s):Helicobacter Infections; Urinary Tract InfectionLast Updated:July 29, 2008Completed
5
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
Condition(s):Gram-Negative Bacterial Infections; Helicobacter Infections; DyspepsiaLast Updated:June 16, 2009Completed
6
Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Condition(s):Urinary Tract Infections; Acute PyelonephritisLast Updated:June 20, 2017Completed
7
Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects
Condition(s):HealthyLast Updated:July 30, 2013Completed